SCHEMBL514743

SCHEMBL514743

[CH2]OC(=O)c1ccccc1SC

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 3/20 0.49
RAB9A P51151 2/20 0.49
HTT P42858 1/20 0.47
ALDH1A1 P00352 4/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 5/20 0.46
HSD17B10 Q99714 3/20 0.46
HPGD P15428 3/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647041 0.82 TSHR (0.71) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL514953 0.81 TSHR (0.51) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL28026600 0.81 TSHR (0.51) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL2027590 0.78 TSHR (0.71) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL515125 0.78 HTT (0.51) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL9669181 0.77 HTT (0.55) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL709788 0.75 POLB (0.68) TSHRTDP1L3MBTL1GAARAB9A
SCHEMBL29391544 0.75 POLB (0.68) TSHRTDP1L3MBTL1GAARAB9A
SCHEMBL26622207 0.75 HTT (0.53) TSHRTDP1L3MBTL1SMN1; SMN2GAA
SCHEMBL2199723 0.75 ALDH1A1 (0.58) TSHRTDP1L3MBTL1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 TSHR 307/4885TDP1 3903/4885L3MBTL1 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.